Archives
-
Affordable GRO-seq for Nascent RNA Profiling in Wheat
2026-10-01
This protocol study introduces an rRNA depletion step between nuclear RNA isolation and nascent RNA immunoprecipitation, making GRO-seq more efficient for allohexaploid bread wheat. The approach increased the proportion of valid sequencing data by 20-fold in the reported application and provides a practical framework for studying enhancer transcription in large, complex genomes.
-
Two-Component Liposomes for mRNA Cancer Vaccines
2026-10-01
A 2026 study developed a stable two-component cationic liposome system that can be mixed with mRNA shortly before administration, avoiding some manufacturing complexity associated with conventional four-lipid nanoparticles. In a murine lymphoma model, optimized CAF04:mRNA formulations generated functional CD8+ T-cell responses, delayed tumor growth, and improved survival, supporting further investigation of adaptable mRNA cancer-vaccine platforms.
-
From WecA Kinetics to Translational Strategy
2026-09-30
A mechanistic and translational analysis of Mycobacterium tuberculosis WecA, showing how membrane-protein biochemistry can become a disciplined anti-tuberculosis discovery cascade—and where Miransertib may serve as a carefully bounded orthogonal pathway tool rather than a direct WecA comparator.
-
A Stereotaxic NSCLC Model for Brain and Spinal Metastases
2026-09-30
The 2024 Heliyon study developed a reproducible intracranial PC-9 Luc xenograft approach for modeling non-small cell lung cancer lesions in the brain and spinal cord. Its central contribution is the use of injection position and cell number as controllable variables, with in vivo optical imaging validated by histopathology.
-
15-PGDH Inhibition Supports Muscle Repair with GLP-1
2026-09-29
A 2026 PNAS study identifies 15-PGDH inhibition as a way to improve muscle regeneration and force recovery during semaglutide-associated weight loss in obese mice. The work separates weight-loss efficacy from muscle quality and provides a preclinical framework for testing regenerative interventions alongside GLP-1 receptor agonists.
-
Anti Reverse Cap Analog for High-Yield mRNA
2026-09-29
Use Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, to build directionally capped Cap 0 mRNA for demanding expression workflows. This guide connects cap selection with IVT optimization, nanoparticle delivery studies, troubleshooting, and translationally relevant assay design.
-
AT-406 (SM-406): From IAP Biology to Translation
2026-09-28
AT-406 (SM-406) illustrates how multi-IAP targeting can connect molecular mechanism with translational cancer research. This article examines its role in apoptosis pathway activation in cancer cells, ovarian cancer combination studies, breast cancer xenograft work, assay design, and biomarker-led development. It also uses the GRA12 Toxoplasma study as a carefully bounded cross-domain perspective on how upstream regulators of cell survival and cellular integrity can shape therapeutic response.
-
Multiplexed CRISPR: From Editing to Translation
2026-09-28
Multiplexed CRISPR can reveal how genes and regulatory elements work together, but simultaneous edits also create biological and analytical complexity. This article turns recent genome-engineering evidence into a practical framework for experimental design, validation, and translational decision-making, including the role of 293T Cells in early assay development.
-
Omeprazole A2845: Assay and Handling Guide
2026-09-27
Omeprazole (A2845) is a research reagent for studying H+,K+-ATPase inhibition and gastric acid secretion, with dossier-reported potency values that can inform assay setup but should not be treated as universal benchmarks. It is for controlled laboratory research only—not diagnosis, treatment, or other medical use—and a chemical-name/formula discrepancy in the dossier should be resolved before experiments.
-
Tricine-SDS-PAGE Electrophoresis System Gel Kit
2026-09-26
The Tricine-SDS-PAGE Gel Preparation Kit is designed to improve separation of low-molecular-weight proteins and peptides that can be difficult to resolve with conventional Tris-SDS-PAGE. It is for research protein electrophoresis, including appropriately configured denaturing or non-denaturing workflows, and is not for diagnostic or medical use.
-
Leptin Fragments in Translational Immunometabolism
2026-09-25
A translational framework for using Leptin (116-130), amide, mouse, to investigate metabolic signaling while drawing careful, testable lessons from recent SIRT6–AMPK–NLRP3 research.
-
OM-MSCs Reduce Golgi Stress After Cerebral I/R Injury
2026-09-25
The study reports that olfactory mucosa mesenchymal stem cells (OM-MSCs) lessen Golgi apparatus stress in cellular and rat models of cerebral ischemia/reperfusion injury, with evidence implicating secreted PEDF and PI3K/Akt/mTOR signaling. Its experimental design connects organelle stress markers to pathway perturbation, while leaving important questions about therapeutic translation and cross-domain use of Akt inhibitors unresolved.
-
Omeprazole (A2845): Research Workflow Guide
2026-09-24
Omeprazole (A2845) provides a research reagent for studying H+,K+-ATPase inhibition and gastric acid secretion, with dossier-reported potency values and DMSO solubility information to guide assay setup. It is intended for controlled research workflows, not for diagnostic or medical use, and its limited aqueous solubility and solution-storage cautions should be considered before dosing.
-
M-CSF and Fibrosis: Building Better Macrophage Models
2026-09-24
A translational perspective on how defined M-CSF inputs can improve macrophage model design—and help researchers interrogate, rather than overinterpret, the IGF2BP1–THBS1–TLR4 findings in pulmonary fibrosis.
-
SW033291 Workflows for 15-PGDH Inhibition
2026-09-23
SW033291 offers a potent way to probe how blocking 15-PGDH changes PGE2 signaling in biochemical, cellular, and regenerative models. This guide turns its target-engagement profile into practical assay workflows—and explains why recent muscle-repair findings are promising class-level evidence, not proof of a SW033291-specific effect.